2-(1,3-Dioxo-1H-benzo[de]isoquinolin-2(3H)-yl)acetic acid
| Title | Journal |
|---|---|
| Copper(II) carboxylate dimers prepared from ligands designed to form a robust π···π stacking synthon: supramolecular structures and molecular properties. | Inorganic chemistry 20120116 |
| The Prostaglandin F Synthase Activity of the Human Aldose Reductase AKR1B1 Brings New Lenses to Look at Pathologic Conditions. | Frontiers in pharmacology 20120101 |
| Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis. | Bioorganic & medicinal chemistry letters 20101101 |
| Diabetic cataract-pathogenesis, epidemiology and treatment. | Journal of ophthalmology 20100101 |
| Advances in pharmacological strategies for the prevention of cataract development. | Indian journal of ophthalmology 20090101 |
| Mechanism of high glucose induced angiotensin II production in rat vascular smooth muscle cells. | Circulation research 20070831 |
| Upregulation of aldose reductase by homocysteine in type II alveolar epithelial cells. | Biochemical and biophysical research communications 20051202 |
| Proteomic analysis of oxidative stress-resistant cells: a specific role for aldose reductase overexpression in cytoprotection. | Molecular & cellular proteomics : MCP 20040201 |
| Neonicotinoid insecticides: reduction and cleavage of imidacloprid nitroimine substituent by liver microsomal and cytosolic enzymes. | Chemical research in toxicology 20020901 |
| Impairment of type III group B Streptococcus-stimulated superoxide production and opsonophagocytosis by neutrophils in diabetes. | Molecular genetics and metabolism 20010701 |
| Aldose reductase inhibitors: a potential new class of agents for the pharmacological control of certain diabetic complications. | Journal of medicinal chemistry 19850701 |
| N-[5-(trifluoromethyl)-6-methoxy-1-naphthalenyl]thioxomethyl]- N-methylglycine (Tolrestat), a potent, orally active aldose reductase inhibitor. | Journal of medicinal chemistry 19840301 |